CLINICAL_TRIALS
research
· 2015-10-06
Clinical Trial Update: Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)
Summary
A clinical trial update examining cardiovascular risks and urinary albumin excretion in Polycystic Ovary Syndrome (PCOS).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Kasr El Aini Hospital | Conditions: Urinary Albumin Excretion | Status: UNKNOWN